MedPath

Effect of probiotic on treatment of bacterial vaginitis and preservation of vaginal bacterial flora in patients treated with metronidazole

Phase 3
Recruiting
Conditions
bacterial vaginosis.
Inflammatory diseases of female pelvic organs
N70-N77
Registration Number
IRCT20180612040071N2
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
128
Inclusion Criteria

Women with bacterial vaginitis according to the Amsel criteria
married
18-48 years old

Exclusion Criteria

People with immunodeficiency disease and HIV
People with genital and urinary tract infections
Antibiotic users within two weeks prior to inclusion
Patients with candidiasis vaginitis
Menopause
Pregnant women or during lactation
Patients who do not allow pelvic examination

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bacterial vaginitis symptoms. Timepoint: 1 month (30dayes ) after the use of probiotics or placebo. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath